RT Journal Article
SR Electronic
A1 Nichols, Emma Hitt
T1 DE-MRI Quantification of Atrial Fibrosis Predicts Ablation Outcome in Patients with Atrial Fibrillation
JF MD Conference Express
YR 2013
FD SAGE Publications
VO 13
IS 3
SP 14
OP 15
DO 10.1177/155989771303007
UL http://mdc.sagepub.com/content/13/3/14.abstract
AB Previous studies demonstrated that the structural changes to the heart that are associated with atrial fibrillation (AF) can be quantified using DE-MRI [Oakes RS et al. Circulation 2009]. This article presents data from the Delayed-Enhancement Magnetic Resonance Imaging (DE-MRI) Determinant of Successful Radiofrequency Catheter Ablation for Atrial Fibrillation trial [DECAAF; NCT01150214]. The DECAAF trial tested the hypothesis that DE-MRI can be used to determine the amount of left atrial fibrosis and/or remodeling, which predicts the patient's response to AF ablation.